These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6968765)

  • 1. A "nonidiotypic" inhibition of influenza-immune H-2-restricted CTL by an anti-T cell serum.
    Effros RB; Hiserodt JC; Bonavida B
    J Immunol; 1980 Nov; 125(5):1879-84. PubMed ID: 6968765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIs locus recognition by a cloned line of H-2-restricted influenza virus-specific cytotoxic T lymphocytes.
    Braciale VL; Braciale TJ
    J Immunol; 1981 Sep; 127(3):859-62. PubMed ID: 6455473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro studies of the rabbit immune system. VI. Rabbit anti-mouse cytotoxic T effector cells are inhibited by anti-rabbit T cell serum in the absence of complement.
    Redelman D; Trefts PE
    J Immunol; 1978 Oct; 121(4):1532-9. PubMed ID: 308967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limit-dilution analysis of weak influenza-immune T cell responses associated with H-2Kb and H-2Db.
    Allouche M; Owen JA; Doherty PC
    J Immunol; 1982 Aug; 129(2):689-93. PubMed ID: 6806380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 induction of hapten-specific cytolytic T cells in nude mice.
    Gillis S; Watson J
    J Immunol; 1981 Apr; 126(4):1245-8. PubMed ID: 6970766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody blockade of lysis by T lymphocyte effectors generated against syngeneic SV40 transformed cells.
    Gooding LR
    J Immunol; 1979 Jun; 122(6):2328-36. PubMed ID: 221583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and LYT-2,3. I. Increased susceptibility to blocking after papain treatment of target cells.
    Gromkowski SH; Heagy W; Sanchez-Madrid F; Springer TA; Martz E
    J Immunol; 1983 Jun; 130(6):2546-51. PubMed ID: 6406593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of idiotype-specific and anti-ACA-1 sera on T cell subpopulations responding to H-2 antigens.
    Nesterenko VG; Rubakova EI; Egorova SG; Suslov AP; Abronina IS
    Folia Biol (Praha); 1984; 30(5):307-16. PubMed ID: 6240416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential analysis of the virus-immune responder characteristics of thymocytes from F1 leads to parent radiation chimeras.
    Korngold R; Doherty PC
    Thymus; 1982 May; 4(3):119-33. PubMed ID: 6981232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza virus-specific cytotoxic T cells are restricted by multiple HLA-A3-related self antigens: evidence for recognition of distinct self structures in conjunction with different foreign antigens.
    Biddison WE; Shearer GM; Shaw S
    J Immunol; 1981 Dec; 127(6):2231-5. PubMed ID: 6975312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloimmune cytolytic T lymphocyte activity: triggering and expression of killing mechanisms in cytolytic T lymphocytes.
    Wei WZ; Lindquist RR
    J Immunol; 1981 Feb; 126(2):513-6. PubMed ID: 6969752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous behavior of H-2Kb in immunity to syngeneic SV40 transformed cells: evidence for cytotoxic T cell recognition of H-2/SV40 membrane antigen complexes.
    Gooding LR
    J Immunol; 1980 Apr; 124(4):1612-9. PubMed ID: 6245126
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytotoxic T lymphocyte responses against alloantigens exhibit preferential effector cell activity for H-2K or H-2D region products similar to that for H-2 restricted responses.
    Lucas CJ; Levy RB; Shearer GM
    J Immunol; 1981 Apr; 126(4):1255-9. PubMed ID: 6970767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of influenza virus-specific cytotoxic T cell responses by monoclonal antibody to a human T cell differentiation antigen.
    Biddison WE; Shearer GM; Chang TW
    J Immunol; 1981 Dec; 127(6):2236-40. PubMed ID: 6457869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of immune lysis. I. Physiological distinction between target cell death mediated by cytotoxic T lymphocytes and antibody plus complement.
    Russell JH; Masakowski VR; Dobos CB
    J Immunol; 1980 Mar; 124(3):1100-5. PubMed ID: 6965686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A monoclonal antibody produced during infection which recognizes an epitope of influenza hemagglutinin only in the context of H-2k MHC class I antigen.
    McLain L; Dimmock NJ
    J Immunol; 1993 Apr; 150(8 Pt 1):3421-6. PubMed ID: 7682240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal molecular requirements for reactivity of tumor cells with T cells.
    Hale AH; Lyles DS; Paulus LK; Ruebush MJ
    J Immunol; 1980 May; 124(5):2063-70. PubMed ID: 6245133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.